Skip to main content

Table 2 Growth inhibitory effect of Cisplatin (ID50) with and without CCI-779

From: Overcoming cisplatin resistance by mTOR inhibitor in lung cancer

 

Cisplatin (ug/ml)

Cisplatin (ug/ml)+ CCI-779

SCLC1

0.15 ± 0.05

0.18 ± 0.02

SR-2

2.52 ± 0.51

0.45 ± 0.03

SCLCB

0.25 ± 0.12

0.14 ± 0.02

SCLCBC

2.57 ± 0.23

0.55 ± 0.04

SCLCL

0.95 ± 0.08

0.3 0 ± 0. 05

NSCLCW

1.2 ± 0.07

0.28 ± 0.04

NSCLCG

1.5 ± 0.5

0.4 ± 0.07